The HeartFlow FFRCT Analysis is the first non-invasive diagnostic tool that aids clinicians in determining, vessel by vessel, both the extent of an artery’s narrowing and the impact that the narrowing has on blood flow to the heart.
By non-invasively identifying which patients do and do not need intervention, clinicians can reduce unnecessary invasive testing, reduce healthcare system costs and improve patient quality of life.
About NICE: NICE is part of the UK Department of Health and provides national guidance and quality standards to improve health and social care throughout the UK. The organization publishes guidelines in several topical areas including the use of health technologies within the UK’s National Health Service (NHS) and clinical practice.
The National Institute for Health and Care Excellence (NICE) issued guidance on 13 February 2017 for the use of the HeartFlow® FFRCT Analysis to help determine the cause of stable chest pain in patients.
1 Douglas, et al. Eur Heart J. 2015.
2 Douglas, et al. J Am Coll Cardiol. 2016.
3 Hlatky, et al. J Am Coll Cardiol. 2015.
4 National Institute for Health and Care Excellence (2017). HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. NICE medical technology guidance, February 2017. London: NICE.